Bookmark

Add to MyYahoo RSS

BioMarin Pharmaceutical News

News on BioMarin Pharmaceutical (Ticker: BMRN) continually updated from thousands of sources around the net.

4 hrs ago | AmericanBankingNews.com

Zacks Reiterates "Neutral" Rating for BioMarin Pharmaceutical

's stock had its "neutral" rating reaffirmed by Zacks in a note issued to investors on Tuesday, American Banking News.com reports.

Comment?

Related Topix: Startups

13 hrs ago | Sys-Con Media

Analysts View on Biotech Equities -- Research on Organovo Holdings,...

The gains were broad based as all the sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 648.05, up 0.51%, while the same has fallen by 1.86% in the previous three months.

Comment?

Related Topix: Startups, Biotech, Vertex Pharmaceuticals, Medicine, Healthcare Industry, Spectrum Pharmaceuticals, Vertex, Financial Markets

Mon Apr 14, 2014

Pharmaceutical Processing

FDA Extends Market Exclusivity of KUVAN Powder for Oral Solution and Tablets

BioMarin Pharmaceutical today announced that the FDA granted KUVAN Powder for Oral Solution and Tablets a six-month pediatric exclusivity extension.

Comment?

Related Topix: Startups, Genetics, Medicine

Fri Apr 11, 2014

Sys-Con Media

Clinical Trial Results and Initiation, Endowment, Product Launches,...

Today, Analysts Review released its analysts' notes regarding Regeneron Pharmaceuticals, Inc. , Questcor Pharmaceuticals, Inc. , Jazz Pharmaceuticals plc , Ariad Pharmaceuticals, Inc. , and BioMarin Pharmaceutical Inc. .

Comment?

Related Topix: Biotech, Medicine, Regeneron Pharmaceuticals, Healthcare Industry, Questcor Pharmaceuticals, Startups, Jazz Pharmaceuticals, ARIAD Pharmaceuticals

Thu Apr 10, 2014

Marin Independent Journal

San Rafael conceptually approves six-story parking garage for BioMarin

San Rafael's Design Review Board has conceptually approved a plan by BioMarin Pharmaceutical to build a six-story parking garage across from the San Rafael Corporate Center bordered by Second Street and Lincoln Avenue.

Comment?

Related Topix: Startups, San Rafael, CA

Mon Apr 07, 2014

The Motley Fool

The AACR Annual Meeting May Move These 2 Stocks

The American Association for Cancer Research meeting shines a bright light on gene testing like that performed by Myriad, and on promising late stage breast cancer treatments, including Pfizer's palbociclib.

Comment?

Related Topix: Medicine, Cancer, Health, Biotech, Myriad Genetics, Healthcare Industry, Breast Cancer, Genetics, Biology, Science, Startups

Tue Apr 01, 2014

BioSpace

Clinovo Release: Silicon Valley BioTalks - Manage Outsourced And In House Clinical Trials

March 31, 2014 -- Outsourcing experts from Onyx Pharmaceuticals, San Francisco State University , BioMarin Pharmaceutical, and Clinovo discussed the topic 'Manage In-house and Outsourced Clinical Trials: Vendor Selection, Project Coordination, and Resource Management' at the eighth Silicon Valley BioTalks.

Comment?

Related Topix: Outsourcing, Startups, South San Francisco, CA, San Francisco, CA

Mon Mar 31, 2014

The Business Journal

Ultragenyx plans to double Marin staff

Coming off a recent $139 million initial public offering of stock, Ultragenyx Pharmaceutical, Inc., is doubling the size of its headquarters as it enters latter stages of research and development of some of its treatments for rare diseases.

Comment?

Related Topix: RARE Hospitality International, Restaurant Management, Novato, CA, Marin County, CA, Startups

Tue Mar 25, 2014

Minyanville

Stock Downgrades: JPMorgan Drives the Corner Store Round the Bend

Blame Moscow if you must, but the root cause of the market's stumbles on Monday lay much closer to home.

Comment?

Related Topix: Mining, Yanzhou Coal Mining Co, Travel/Tourism, Carnival Cruise, Office Equipment, Furniture, SCS, Walgreens, Retail, Startups

Mon Mar 24, 2014

AmericanBankingNews.com

Goldman Sachs Downgrades BioMarin Pharmaceutical to Neutral

Shares of BioMarin Pharmaceutical traded down 0.30% during mid-day trading on Monday, hitting $73.71.

Comment?

Related Topix: Startups

Fri Mar 21, 2014

BioSpace

BioMarin Pharmaceutical Inc. Appoints Pioneer In Personalized Medicine, To Board Of Directors

BioMarin Pharmaceutical Inc. , a global leader in providing therapies for rare genetic diseases, today announced the appointment of Dennis J. Slamon, M.D., Ph.D., director of Clinical/Translational Research and director of the Revlon/UCLA Women's Cancer Research Program at UCLA's Jonsson Comprehensive Cancer Center, to the company's board of ... (more)

Comment?

Related Topix: Startups, Genetics, Medicine

AmericanBankingNews.com

BioMarin Pharmaceutical Receives Consensus Recommendation of "Buy" from Analysts

Shares of BioMarin Pharmaceutical have earned a consensus recommendation of "Buy" from the thirteen ratings firms that are currently covering the company, Stock Ratings Network.com reports .

Comment?

Related Topix: Startups

Wed Mar 19, 2014

GlobeNewswire

Catalyst Pharmaceutical Partners Announces Fourth Quarter and...

Catalyst Pharmaceutical Partners, Inc. , a specialty pharmaceutical company focused on developing safe and effective approved medicines targeting orphan neuromuscular and neurological diseases today reported financial results for the fourth quarter and year-ended December 31, 2013.

Comment?

Related Topix: Biotech, Catalyst Pharmaceutical Partners, Startups

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••
•••